
Overview
I mainly treat patients with genitourinary cancers including prostate, kidney, bladder, testicular and penile cancer. My goal is to be attentive and devoted to my patients who are often dealing with complicated health problems. I try to personalize my care because every patient is different. I believe the future is promising because new treatments are being discovered every day. I am involved in clinical trials done through Duke University. Clinical trials are designed to provide patients with access to the newest possible treatments. I am also part of our multi-disciplinary cancer team including urologic oncologists, geneticists, radiation oncologists, pathologists, radiologists, and other specialists. I grew up in Cary and did all of my medical training in the Research Triangle Park area. I feel honored to practice in the same community I have lived in for more than twenty-five years.
Dr. Ramalingam is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Muscle Invasive Bladder Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Multiple Myeloma.
His clinical research consists of co-authoring 18 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
216 Ashville Ave, Cary, NC 27518
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Duke Cancer Center
When someone is faced with a diagnosis of lung cancer, they may be going through surgery, radiation treatment, chemotherapy or enrolling in a clinical trial. It’s a very complicated process to understand what’s involved and what may happen next. It’s also hard to hear all the answers if you’re by yourself. We encourage our patients to come with family members and friends and loved ones and particularly to identify one or two main go-to people in terms of care-giving and support. That way we can engage them in the whole process. Just as we have a team taking care of the patient, the patient has a team, too. At Duke, we have the opportunity to engage patients in the very latest treatment approaches, whether it’s a new surgical technique, the latest radiation approach, or some novel chemotherapy, immunology, or targeted therapy, several of which we’ve been developing. Duke provides patients with a real opportunity that they may not have elsewhere. Dr. Crawford is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer.
Wakemed Specialists Group LLC
Praveen Namireddy is a Hematologist Oncology specialist and a Hematologist in Raleigh, North Carolina. Dr. Namireddy is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma. Dr. Namireddy is currently accepting new patients.
Southeastern Medical Oncology Center
Samer Kasbari is a Hematologist Oncology specialist and a Hematologist in Goldsboro, North Carolina. Dr. Kasbari is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Colorectal Cancer, Small Cell Lung Cancer (SCLC), Endoscopy, and Bone Marrow Aspiration. Dr. Kasbari is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Muscle Invasive Bladder CancerDr. Ramalingam isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Upper Tract Urothelial Carcinoma (UTUC)Dr. Ramalingam isDistinguished. Learn about Upper Tract Urothelial Carcinoma (UTUC).
- Advanced
- Adult T-Cell LeukemiaDr. Ramalingam isAdvanced. Learn about Adult T-Cell Leukemia.
- Chronic T-Cell Leukemia (CTCL)Dr. Ramalingam isAdvanced. Learn about Chronic T-Cell Leukemia (CTCL).
- Large-Cell Immunoblastic LymphomaDr. Ramalingam isAdvanced. Learn about Large-Cell Immunoblastic Lymphoma.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Ramalingam isAdvanced. Learn about Multiple Myeloma.
- Non-Muscle Invasive Bladder CancerDr. Ramalingam isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Experienced
- Adult Immune ThrombocytopeniaDr. Ramalingam isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Ramalingam isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Ramalingam isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Ramalingam isExperienced. Learn about Anemia.
- Antiphospholipid SyndromeDr. Ramalingam isExperienced. Learn about Antiphospholipid Syndrome.
- Arterial EmbolismDr. Ramalingam isExperienced. Learn about Arterial Embolism.

